Table 2 Pathway analysis of significantly decreased genes in AD-MSCs, COPD vs control
Source | term_name | term_id | adjusted_p_value |
|---|---|---|---|
GO:MF | Heparin binding | GO:0008201 | 0.000161618 |
GO:MF | Glycosaminoglycan binding | GO:0005539 | 0.000876765 |
GO:MF | Signaling receptor binding | GO:0005102 | 0.001008396 |
GO:MF | Sulfur compound binding | GO:1901681 | 0.001657873 |
GO:MF | Fibronectin binding | GO:0001968 | 0.003329845 |
GO:MF | Insulin-like growth factor binding | GO:0005520 | 0.021832888 |
GO:MF | Platelet-derived growth factor-activated receptor activity | GO:0005017 | 0.0291196 |
GO:MF | Molecular transducer activity | GO:0060089 | 0.039974476 |
GO:BP | Negative regulation of response to wounding | GO:1903035 | 0.000141464 |
GO:BP | Regulation of cell communication | GO:0010646 | 0.000257333 |